DE3682780D1 - Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren. - Google Patents

Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren.

Info

Publication number
DE3682780D1
DE3682780D1 DE8686904864T DE3682780T DE3682780D1 DE 3682780 D1 DE3682780 D1 DE 3682780D1 DE 8686904864 T DE8686904864 T DE 8686904864T DE 3682780 T DE3682780 T DE 3682780T DE 3682780 D1 DE3682780 D1 DE 3682780D1
Authority
DE
Germany
Prior art keywords
pct
localization
diagnosis
tumors
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686904864T
Other languages
English (en)
Inventor
Ward Page Faulk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3682780D1 publication Critical patent/DE3682780D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
DE8686904864T 1985-08-02 1986-08-01 Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren. Expired - Lifetime DE3682780D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858519457A GB8519457D0 (en) 1985-08-02 1985-08-02 Tumour imaging agents
PCT/GB1986/000464 WO1987000756A1 (en) 1985-08-02 1986-08-01 Agents for use in tumour diagnosis, imaging, localization or treatment

Publications (1)

Publication Number Publication Date
DE3682780D1 true DE3682780D1 (de) 1992-01-16

Family

ID=10583220

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686904864T Expired - Lifetime DE3682780D1 (de) 1985-08-02 1986-08-01 Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren.

Country Status (8)

Country Link
US (2) US4895714A (de)
EP (1) EP0272257B1 (de)
JP (1) JPS63502747A (de)
AT (1) ATE69956T1 (de)
AU (1) AU6198086A (de)
DE (1) DE3682780D1 (de)
GB (1) GB8519457D0 (de)
WO (1) WO1987000756A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206346A (en) * 1990-12-05 1993-04-27 E. I. Du Pont De Nemours And Company Method for iodination/purification
AU3783893A (en) * 1992-02-28 1993-09-13 Stanley E. Order Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor
US7097839B1 (en) * 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US20030021792A1 (en) * 2001-06-08 2003-01-30 Roben Paul W. Tissue-specific endothelial membrane proteins
AU2001249503A1 (en) 2000-03-27 2001-10-08 Thomas Jefferson University High specificity marker detection
CA2414401A1 (en) * 2000-06-28 2002-01-03 Ward Page Faulk Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
US20040028686A1 (en) * 2001-06-28 2004-02-12 Faulk Ward Page Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplated organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
CN100372566C (zh) 2001-05-15 2008-03-05 福克医药公司 治疗病毒感染的靶向给药组合物及方法
WO2002094271A1 (en) * 2001-05-15 2002-11-28 Faulk Pharmaceuticals, Inc. Targeted delivery of bioaffecting compounds for the treatment of cancer
EP1414299B1 (de) * 2001-05-15 2011-05-04 Faulk Pharmaceuticals, Inc. Verfahren zur herstellung eines homogenen doxorubicin-transferrin kojugates
CA2447395A1 (en) * 2001-05-16 2002-11-21 Faulk Pharmaceuticals, Inc. Targeted delivery of drugs for the treatment of parasitic infections
US7208271B2 (en) 2001-11-28 2007-04-24 Applera Corporation Compositions and methods of selective nucleic acid isolation
WO2003086272A2 (en) * 2002-04-16 2003-10-23 Kamada Ltd. Ultrapure transferrin for pharmaceutical compositions
US7592143B2 (en) * 2003-04-18 2009-09-22 Cytovia, Inc. Methods of treating diseases responsive to induction of apoptosis and screening assays
US20040220390A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for the treatment of tumors
US20040219097A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for the diagnosis, imaging and treatment of tumors
US20040220085A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Compositions for nucleic acid delivery
US20040219103A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods useful for the diagnosis, imaging and treatment of tumors
US20040220084A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods for nucleic acid delivery
US20040219102A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Compositions for drug delivery
US20040220121A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods for drug delivery
US20040219104A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Methods for treatment of tumors
US20040219100A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for the treatment of tumors
US20040219101A1 (en) * 2003-05-02 2004-11-04 Jasbir Sandhu Composition useful for treatment of tumors
US20100015051A1 (en) * 2004-09-30 2010-01-21 Labhasetwar Vinod D Transferrin-conjugated nanoparticles for increasing efficacy of a therapeutic agent
CN1686562A (zh) * 2005-03-31 2005-10-26 南京大学 一种转铁蛋白与生物还原剂的结合物及其制备方法
EP2216341A1 (de) 2009-02-10 2010-08-11 Novozymes Biopharma UK Limited Transferrinvarianten und -konjugate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2108528A1 (de) * 1971-02-23 1972-09-21 Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt Verfahren zur Herstellung von mit Indium 113m markiertem Humantransfernn
DE2150000A1 (de) * 1971-10-07 1973-04-12 Hoechst Ag Metall-transferrin-aggregate, ihre herstellung und ihre verwendung als diagnosticum
DE2239791A1 (de) * 1972-08-12 1974-02-21 Hoechst Ag Verfahren zur herstellung von mit indium-113m markiertem humantransferrin
DE2964024D1 (en) * 1978-10-02 1982-12-16 Procter & Gamble Liposomes for drug delivery and composition containing a liposome drug system
EP0027260B1 (de) * 1979-10-11 1985-03-13 Fujisawa Pharmaceutical Co., Ltd. Peptide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4447547A (en) * 1980-04-09 1984-05-08 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
US4448762A (en) * 1980-11-03 1984-05-15 The United States Of America As Represented By The United States Department Of Energy Complex of transferrin with ruthenium for medical applications
US4448763A (en) * 1980-11-10 1984-05-15 The University Of Kentucky Research Foundation Alteration of gallium biodistribution using indium complexes for enhanced early imaging
US4434156A (en) * 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
JPS60126231A (ja) * 1983-12-09 1985-07-05 Seitai Kagaku Kenkyusho:Kk 放射性診断剤

Also Published As

Publication number Publication date
EP0272257B1 (de) 1991-12-04
AU6198086A (en) 1987-03-05
US4895714A (en) 1990-01-23
JPS63502747A (ja) 1988-10-13
GB8519457D0 (en) 1985-09-11
EP0272257A1 (de) 1988-06-29
WO1987000756A1 (en) 1987-02-12
US5000935A (en) 1991-03-19
ATE69956T1 (de) 1991-12-15

Similar Documents

Publication Publication Date Title
DE3682780D1 (de) Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren.
IL65705A (en) Medical apparatus for performing isocentric examinations
DE3680924D1 (de) Metall-radionuklid markiertes protein fuer diagnose und therapie.
FR2597326B1 (fr) Procede pour identifier des lesions tissulaires eventuelles lors de l'application medicale d'un son de haute energie.
MX9101999A (es) Agentes complejantes e inmunoreactivos radioactivos de objetivo, utiles en composiciones y metodos de formacion de imagen terapeuticos y de diagnostico.
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
DE3272377D1 (en) An x-ray computerized tomographic apparatus
DE3782440D1 (de) Verfahren und ausruestung zur herstellung von radioaktivmarkierten antikoerpern fuer die in-vivo-krebsdiagnose und therapie.
DE69017370D1 (de) Röntgenuntersuchungsapparat.
DE3782088D1 (de) Verfahren zur herstellung von fluoroskopischen und radiographischen roentgenbildern und ein nach diesem verfahren arbeitender, tragbarer diagnostikapparat.
FR2508790B1 (fr) Appareil de diagnostic a rayonnement
DK78183D0 (da) Antistoffer og antigener, der er nyttige til diagnose og behandling af cancer
DE69330494T2 (de) Radioaktiv markierte somatostatin
NO163435C (no) Pasientstol for roentgenundersoekelser.
DE59007439D1 (de) Zahnärztliche Röntgendiagnostikeinrichtung.
PT69525A (fr) Installation de traite d'animaux en particulier des brebis
ZA824983B (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
MX9200413A (es) Composicion farmaceutica para el tratamiento y/o diagnostico de tumores de tejido blando.
DE3689811D1 (de) Vorrichtungen und Verfahren zur Strahlungsabbildung von Röntgenstrahlen.
DE2861257D1 (en) Diagnostic kit for blood pool imaging
WO1990003802A3 (en) Technetium imaging agents
DE58907799D1 (de) Röntgenbildverstärker.
RO82047A (ro) Procedeu de stimulare a ovulatiei la animale femele
ATE25336T1 (de) Mittel fuer die scintigraphie.
DE3774746D1 (de) Roentgenstrahlenbildverstaerker.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee